$83.69B Market Cap.
CME Market Cap. (MRY)
CME Shares Outstanding (MRY)
CME Assets (MRY)
Total Assets
$137.45B
Total Liabilities
$110.96B
Total Investments
$99.01B
CME Income (MRY)
Revenue
$6.13B
Net Income
$3.48B
Operating Expense
$2.20B
CME Cash Flow (MRY)
CF Operations
$3.69B
CF Investing
-$82.60M
CF Financing
$5.08B
CME Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $10.40 | 4.50% | 7.77% | 107.33% | 0.93 |
2023 | $9.65 | 4.60% | 13.53% | 108.79% | 0.92 |
2022 | $8.50 | 5.10% | 24.09% | 114.71% | 0.87 |
2021 | $6.85 | 3.00% | 16.10% | 93.84% | 1.07 |
2020 | $5.90 | 3.20% | - | 100.34% | 1.00 |
CME Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $137,447,000,000 (5.97%) | $129,706,100,000 (-25.53%) | $174,175,700,000 (-11.49%) | $196,780,300,000 (57.85%) |
Assets Current | $103,033,500,000 (8.58%) | $94,890,200,000 (-31.77%) | $139,078,300,000 (-14.02%) | $161,761,800,000 (81.18%) |
Assets Non-Current | $34,413,500,000 (-1.16%) | $34,815,900,000 (-0.80%) | $35,097,400,000 (0.23%) | $35,018,500,000 (-1.01%) |
Goodwill & Intangible Assets | $30,483,800,000 (-0.77%) | $30,720,800,000 (-0.67%) | $30,927,500,000 (-0.99%) | $31,235,300,000 (-4.88%) |
Shareholders Equity | $26,486,900,000 (-0.94%) | $26,737,900,000 (-0.52%) | $26,878,700,000 (-1.90%) | $27,399,300,000 (4.10%) |
Property Plant & Equipment Net | $386,200,000 (-5.69%) | $409,500,000 (-10.10%) | $455,500,000 (-9.86%) | $505,300,000 (-12.76%) |
Cash & Equivalents | $2,892,400,000 (-0.67%) | $2,912,000,000 (7.05%) | $2,720,100,000 (-4.05%) | $2,834,900,000 (73.58%) |
Accumulated Other Comprehensive Income | -$105,500,000 (-89.75%) | -$55,600,000 (58.29%) | -$133,300,000 (-349.16%) | $53,500,000 (-60.34%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $99,008,600,000 (9.64%) | $90,304,200,000 (-33.28%) | $135,345,200,000 (-14.37%) | $158,064,600,000 (81.93%) |
Investments Current | $99,008,600,000 (9.64%) | $90,304,200,000 (-33.28%) | $135,345,200,000 (-14.37%) | $158,064,600,000 (81.93%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $573,100,000 (7.00%) | $535,600,000 (10.84%) | $483,200,000 (11.21%) | $434,500,000 (-5.81%) |
Trade & Non-Trade Payables | $79,900,000 (-11.81%) | $90,600,000 (-25.37%) | $121,400,000 (148.77%) | $48,800,000 (-29.58%) |
Accumulated Retained Earnings (Deficit) | $4,185,800,000 (-6.05%) | $4,455,200,000 (-6.14%) | $4,746,800,000 (-7.86%) | $5,151,900,000 (3.12%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $5,246,800,000 (-1.52%) | $5,327,700,000 (-0.62%) | $5,361,100,000 (-0.54%) | $5,390,400,000 (-3.86%) |
Total Debt | $102,323,400,000 (9.30%) | $93,617,900,000 (-32.50%) | $138,687,600,000 (-14.07%) | $161,394,700,000 (78.88%) |
Debt Current | $99,645,200,000 (10.48%) | $90,192,500,000 (-33.32%) | $135,265,200,000 (-14.77%) | $158,699,000,000 (82.87%) |
Debt Non-Current | $2,678,200,000 (-21.81%) | $3,425,400,000 (0.09%) | $3,422,400,000 (26.96%) | $2,695,700,000 (-21.72%) |
Total Liabilities | $110,960,100,000 (7.76%) | $102,968,200,000 (-30.09%) | $147,297,000,000 (-13.04%) | $169,381,000,000 (72.30%) |
Liabilities Current | $102,313,900,000 (9.52%) | $93,416,900,000 (-32.15%) | $137,687,500,000 (-14.16%) | $160,398,400,000 (81.86%) |
Liabilities Non-Current | $8,646,200,000 (-9.48%) | $9,551,300,000 (-0.61%) | $9,609,500,000 (6.98%) | $8,982,600,000 (-11.15%) |
CME Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $6,130,100,000 (9.88%) | $5,578,900,000 (11.15%) | $5,019,400,000 (7.03%) | $4,689,700,000 (-3.97%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $1,338,400,000 (3.29%) | $1,295,800,000 (7.05%) | $1,210,500,000 (-1.23%) | $1,225,600,000 (-5.19%) |
Research & Development Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Expenses | $2,198,600,000 (2.58%) | $2,143,200,000 (6.97%) | $2,003,500,000 (-2.01%) | $2,044,500,000 (-8.98%) |
Interest Expense | $160,900,000 (0.94%) | $159,400,000 (-2.03%) | $162,700,000 (-2.52%) | $166,900,000 (0.42%) |
Income Tax Expense | $1,015,600,000 (9.51%) | $927,400,000 (16.03%) | $799,300,000 (8.50%) | $736,700,000 (19.65%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $3,525,800,000 (9.29%) | $3,226,200,000 (19.89%) | $2,691,000,000 (2.05%) | $2,636,900,000 (25.19%) |
Net Income to Non-Controlling Interests | $44,300,000 (0%) | $0 (0%) | $0 (0%) | $500,000 (-58.33%) |
Net Income | $3,481,500,000 (7.91%) | $3,226,200,000 (19.89%) | $2,691,000,000 (2.07%) | $2,636,400,000 (25.23%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $40,600,000 (20.12%) | $33,800,000 (75.13%) | $19,300,000 (0%) |
Net Income Common Stock | $3,481,500,000 (9.29%) | $3,185,600,000 (19.89%) | $2,657,200,000 (1.53%) | $2,617,100,000 (24.32%) |
Weighted Average Shares | $359,389,000 (0.10%) | $359,023,000 (0.09%) | $358,713,000 (0.10%) | $358,340,000 (0.16%) |
Weighted Average Shares Diluted | $359,944,000 (0.12%) | $359,500,000 (0.09%) | $359,181,000 (0.07%) | $358,929,000 (0.11%) |
Earning Before Interest & Taxes (EBIT) | $4,658,000,000 (8.00%) | $4,313,000,000 (18.07%) | $3,653,000,000 (3.19%) | $3,540,000,000 (22.61%) |
Gross Profit | $6,130,100,000 (9.88%) | $5,578,900,000 (11.15%) | $5,019,400,000 (7.03%) | $4,689,700,000 (-3.97%) |
Operating Income | $3,931,500,000 (14.43%) | $3,435,700,000 (13.92%) | $3,015,900,000 (14.01%) | $2,645,200,000 (0.30%) |
CME Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$82,600,000 (-495.22%) | $20,900,000 (104.27%) | -$489,800,000 (-938.70%) | $58,400,000 (133.28%) |
Net Cash Flow from Financing | $5,076,500,000 (110.50%) | -$48,339,300,000 (-90.45%) | -$25,381,700,000 (-136.31%) | $69,908,700,000 (47.97%) |
Net Cash Flow from Operations | $3,690,500,000 (6.85%) | $3,453,800,000 (13.02%) | $3,056,000,000 (27.21%) | $2,402,400,000 (-11.53%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $8,684,400,000 (119.36%) | -$44,864,600,000 (-96.64%) | -$22,815,500,000 (-131.53%) | $72,369,500,000 (45.36%) |
Net Cash Flow - Business Acquisitions and Disposals | $9,900,000 (-89.63%) | $95,500,000 (123.76%) | -$402,000,000 (-377.82%) | $144,700,000 (595.67%) |
Net Cash Flow - Investment Acquisitions and Disposals | $1,500,000 (-16.67%) | $1,800,000 (-5.26%) | $1,900,000 (18.75%) | $1,600,000 (33.33%) |
Capital Expenditure | -$94,000,000 (-23.04%) | -$76,400,000 (14.83%) | -$89,700,000 (-2.05%) | -$87,900,000 (55.49%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$16,400,000 (-7.89%) | -$15,200,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Payment of Dividends & Other Cash Distributions | -$3,584,200,000 (-10.78%) | -$3,235,500,000 (-22.86%) | -$2,633,500,000 (-20.29%) | -$2,189,300,000 (-3.76%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $89,500,000 (7.96%) | $82,900,000 (-1.66%) | $84,300,000 (12.10%) | $75,200,000 (-21.67%) |
Depreciation Amortization & Accretion | $336,800,000 (-4.48%) | $352,600,000 (-2.76%) | $362,600,000 (-5.92%) | $385,400,000 (-17.01%) |
CME Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | 56.80% (-0.53%) | 57.10% (7.94%) | 52.90% (-5.20%) | 55.80% (29.47%) |
EBITDA Margin | 81.50% (-2.51%) | 83.60% (4.50%) | 80.00% (-4.42%) | 83.70% (22.01%) |
Return on Average Equity (ROAE) | 12.70% (9.48%) | 11.60% (20.83%) | 9.60% (-1.03%) | 9.70% (22.78%) |
Return on Average Assets (ROAA) | 2.60% (18.18%) | 2.20% (57.14%) | 1.40% (0.00%) | 1.40% (-17.65%) |
Return on Sales (ROS) | 76.00% (-1.68%) | 77.30% (6.18%) | 72.80% (-3.58%) | 75.50% (27.75%) |
Return on Invested Capital (ROIC) | 4.60% (21.05%) | 3.80% (58.33%) | 2.40% (0.00%) | 2.40% (-20.00%) |
Dividend Yield | 4.50% (-2.17%) | 4.60% (-9.80%) | 5.10% (70.00%) | 3.00% (-6.25%) |
Price to Earnings Ratio (P/E) | 23.97 (0.94%) | 23.74 (4.62%) | 22.69 (-27.49%) | 31.3 (1.08%) |
Price to Sales Ratio (P/S) | 13.62 (0.46%) | 13.55 (12.77%) | 12.02 (-31.16%) | 17.46 (30.89%) |
Price to Book Ratio (P/B) | 3.16 (11.46%) | 2.83 (25.94%) | 2.25 (-24.89%) | 3 (20.70%) |
Debt to Equity Ratio (D/E) | 4.19 (8.78%) | 3.85 (-29.73%) | 5.48 (-11.36%) | 6.18 (65.52%) |
Earnings Per Share (EPS) | 9.69 (9.24%) | 8.87 (19.70%) | 7.41 (1.51%) | 7.3 (24.15%) |
Sales Per Share (SPS) | 17.06 (9.77%) | 15.54 (11.05%) | 13.99 (6.92%) | 13.09 (-4.12%) |
Free Cash Flow Per Share (FCFPS) | 10.01 (6.38%) | 9.41 (13.76%) | 8.27 (28.02%) | 6.46 (-8.23%) |
Book Value Per Share (BVPS) | 73.7 (-1.04%) | 74.47 (-0.61%) | 74.93 (-2.00%) | 76.46 (3.93%) |
Tangible Assets Book Value Per Share (TABVPS) | 297.63 (7.95%) | 275.71 (-30.96%) | 399.34 (-13.56%) | 461.98 (80.00%) |
Enterprise Value Over EBIT (EV/EBIT) | 40 (5.26%) | 38 (-30.91%) | 55 (-16.67%) | 66 (22.22%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 36.89 (4.86%) | 35.18 (-29.99%) | 50.25 (-15.45%) | 59.43 (28.05%) |
Asset Turnover | 0.05 (17.95%) | 0.04 (44.44%) | 0.03 (3.85%) | 0.03 (-33.33%) |
Current Ratio | 1.01 (-0.89%) | 1.02 (0.59%) | 1.01 (0.10%) | 1.01 (-0.30%) |
Dividends | $10.4 (7.77%) | $9.65 (13.53%) | $8.5 (24.09%) | $6.85 (16.10%) |
Free Cash Flow (FCF) | $3,596,500,000 (6.49%) | $3,377,400,000 (13.86%) | $2,966,300,000 (28.16%) | $2,314,500,000 (-8.09%) |
Enterprise Value (EV) | $184,248,784,080 (12.26%) | $164,130,730,925 (-18.66%) | $201,772,668,891 (-13.51%) | $233,285,042,798 (49.98%) |
Earnings Before Tax (EBT) | $4,497,100,000 (8.27%) | $4,153,600,000 (19.00%) | $3,490,300,000 (3.47%) | $3,373,100,000 (23.97%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $4,994,800,000 (7.06%) | $4,665,600,000 (16.19%) | $4,015,600,000 (2.30%) | $3,925,400,000 (17.12%) |
Invested Capital | $104,080,300,000 (8.11%) | $96,274,300,000 (-31.98%) | $141,528,200,000 (-13.55%) | $163,706,400,000 (77.53%) |
Working Capital | $719,600,000 (-51.16%) | $1,473,300,000 (5.93%) | $1,390,800,000 (2.01%) | $1,363,400,000 (25.54%) |
Tangible Asset Value | $106,963,200,000 (8.06%) | $98,985,300,000 (-30.90%) | $143,248,200,000 (-13.47%) | $165,545,000,000 (80.29%) |
Market Capitalization | $83,686,484,080 (10.38%) | $75,814,130,925 (25.33%) | $60,491,568,891 (-26.33%) | $82,107,942,798 (25.64%) |
Average Equity | $27,373,275,000 (-0.54%) | $27,522,925,000 (-0.70%) | $27,717,000,000 (2.68%) | $26,993,125,000 (1.22%) |
Average Assets | $132,668,775,000 (-7.33%) | $143,160,050,000 (-22.11%) | $183,799,050,000 (1.70%) | $180,726,450,000 (42.99%) |
Invested Capital Average | $101,477,600,000 (-9.60%) | $112,251,825,000 (-26.61%) | $152,948,375,000 (1.99%) | $149,960,075,000 (58.11%) |
Shares | 360,360,350 (0.10%) | 359,991,125 (0.07%) | 359,726,266 (0.09%) | 359,397,456 (0.11%) |
